Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Below Guidance

Go back to Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 5c, Revenues Beat; Offers FY19 Revenue Below Guidance
(NASDAQ: AQST) Delayed: 4.78 +0.17 (3.69%)
Previous Close $4.61    52 Week High
Open $4.65    52 Week Low
Day High $4.83    P/E N/A 
Day Low $4.56    EPS
Volume 2,455,963